RELOMVIC Trademark

Trademark Overview

On Friday, September 5, 2014, a trademark application was filed for RELOMVIC with the United States Patent and Trademark Office. The USPTO has given the RELOMVIC trademark a serial number of 86387040. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 2, 2018. This trademark is owned by Amgen Inc.. The RELOMVIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cholesterol related diseases and disorders
relomvic

General Information

Serial Number86387040
Word MarkRELOMVIC
Filing DateFriday, September 5, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 2, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 30, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cholesterol related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 16, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, April 2, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 2, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, August 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 17, 2017EXTENSION 5 GRANTED
Thursday, August 3, 2017EXTENSION 5 FILED
Thursday, August 3, 2017TEAS EXTENSION RECEIVED
Tuesday, February 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2017EXTENSION 4 GRANTED
Monday, January 30, 2017EXTENSION 4 FILED
Monday, January 30, 2017TEAS EXTENSION RECEIVED
Wednesday, August 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 23, 2016EXTENSION 3 GRANTED
Friday, August 19, 2016EXTENSION 3 FILED
Friday, August 19, 2016TEAS EXTENSION RECEIVED
Thursday, March 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2016EXTENSION 2 GRANTED
Thursday, February 18, 2016EXTENSION 2 FILED
Tuesday, March 22, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 18, 2016TEAS EXTENSION RECEIVED
Saturday, August 8, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 6, 2015EXTENSION 1 GRANTED
Thursday, August 6, 2015EXTENSION 1 FILED
Thursday, August 6, 2015TEAS EXTENSION RECEIVED
Tuesday, February 24, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 30, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 30, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 10, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 25, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 21, 2014EXAMINER'S AMENDMENT ENTERED
Friday, November 21, 2014ASSIGNED TO LIE
Friday, November 21, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 21, 2014EXAMINERS AMENDMENT E-MAILED
Friday, November 21, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 19, 2014ASSIGNED TO EXAMINER
Tuesday, September 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 9, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

relomvic diseases disorders related cholesterol preparations treatment pharmaceutical